| |
|
|
|
Entera Bio Ltd  
|
|
1.96 0.03 (0.02%) |
06-05 16:00 |
|
Open: |
1.92 |
Pre close: |
1.93 |
Target:
|
3.15
|
|
High: |
2.05 |
Low: |
1.8397 |
Resistance:
|
2.69
3.34
|
|
Volume: |
218,923 |
Market Cap: |
36M |
Support:
|
1.65
1.37
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.94
 |
MACD |
MACD(12,26):
|
-0.07  |
|
MA(20): |
2.19 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.48 |
Stochastic Oscillator |
%K(14,3):
|
16.75 |
|
MA(250): |
2.61 |
%D(3): |
16.48 |
|
Average Volume(K) |
3-Month: |
5306
|
52-Week |
High:
|
4.00 |
|
10-Days: |
21692 |
Low: |
1.35 |
|
RSI |
RSI(14):
|
44.94 |
Change(%): |
-48.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.890 |
Return on Equity (ttm) |
-98.0 |
Shares Out. (M) |
17.86 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-47.7 |
Shares Float (M) |
8.84 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.22 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-79.6 |
% Held by Institutions |
10.55 |
|
Forward EPS |
1.310 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
4 |
|
Book Value (p.s.) |
0.670 |
EBITDA (p.s.) |
-0.635 |
P/E |
-2.20 |
|
Sales Per Share |
0.013 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.92 |
P/S |
148.33 |
|
Operating Margin |
-4853.39 |
Levered Free Cash Flow
(M) |
-3.62 |
P/CF |
-3.92 |
|
|
|
|
|
|
